Heidelberg Pharma AG (ETR:HPHA)

PRESS RELEASE

published on 03/18/2026 at 06:55, 3 months 26 days ago

Heidelberg Pharma to Receive Milestone Payment from Partner Huadong for Clinical Study with HDP-101 in China
Heidelberg Pharma to receive milestone payment from partner Huadong for clinical study with HDP-101 in China. First patient dosed in Phase I study evaluating safety, tolerability, and efficacy

China Clinical Study Heidelberg Pharma HDP-101 Milestone Payment
BRIEF

published on 03/09/2026 at 07:17, 4 months 4 days ago

Heidelberg Pharma Amends Royalty Agreement with HealthCare Royalty and Soleus Capital Joins

FDA Approval Heidelberg Pharma Royalty Agreement Soleus Capital Biotech Investment
BRIEF

published on 03/09/2026 at 07:17, 4 months 4 days ago

Heidelberg Pharma modifie son accord de redevances avec HealthCare Royalty et Soleus Capital se joint à la procédure.

Heidelberg Pharma Approbation De La FDA Soleus Capital Investissement En Biotechnologie Contrat De Redevances
PRESS RELEASE

published on 03/09/2026 at 07:12, 4 months 4 days ago

Heidelberg Pharma and HealthCare Royalty Announce Amendment to Existing Royalty Agreement and the Participation of Soleus Capital
Heidelberg Pharma AG announces amendment to royalty agreement with HealthCare Royalty and participation of Soleus Capital, securing financing until mid-2027. USD 20 million upfront from Soleus Capital and USD 25 million upon FDA approval of TLX250-Px

FDA Approval Heidelberg Pharma HealthCare Royalty Royalty Agreement Soleus Capital
BRIEF

published on 03/07/2026 at 02:08, 4 months 7 days ago

Heidelberg Pharma modifie son accord de redevances avec HealthCare Royalty et Soleus Capital

Heidelberg Pharma Soleus Capital Contrat De Redevances TLX250-Px Royauté Des Soins De Santé
BRIEF

published on 03/07/2026 at 02:08, 4 months 7 days ago

Heidelberg Pharma Modifies Royalty Agreement with HealthCare Royalty and Soleus Capital

Heidelberg Pharma HealthCare Royalty Royalty Agreement Soleus Capital TLX250-Px
PRESS RELEASE

published on 03/07/2026 at 02:03, 4 months 7 days ago

EQS-Adhoc: Heidelberg Pharma and HealthCare Royalty Announce Amendment to Existing Royalty Agreement and the Participation of Soleus Capital
Heidelberg Pharma AG announces amendment to royalty agreement with HealthCare Royalty and partnership with Soleus Capital, securing upfront and milestone payments

FDA Approval HealthCare Royalty Heidelberg Pharma AG Royalty Agreement Soleus Capital
BRIEF

published on 01/29/2026 at 13:32, 5 months 15 days ago

Heidelberg Pharma Attains Milestone Payment from Takeda

Clinical Development Heidelberg Pharma Milestone Payment ATAC Technology Takeda Partnership
BRIEF

published on 01/29/2026 at 13:32, 5 months 15 days ago

Heidelberg Pharma obtient un paiement d'étape de Takeda

Développement Clinique Heidelberg Pharma Paiement D'étape Partenariat Takeda Technologie ATAC
PRESS RELEASE

published on 01/29/2026 at 13:27, 5 months 15 days ago

Heidelberg Pharma Received Development Milestone Payment from Partner Takeda
Heidelberg Pharma AG receives development milestone payment from partner Takeda for progress in ADC technology clinical trial

Takeda Clinical Trial Heidelberg Pharma ADC Technology Development Milestone

Published on 07/14/2026 at 01:45, 4 hours 9 minutes ago

Arctic Fox Lithium Approved for Trading on the OTCQB Venture Market and Announces DTC Eligibility
Published on 07/14/2026 at 00:01, 5 hours 53 minutes ago

Captor Capital Announces Delay in its Annual Filings
Published on 07/13/2026 at 23:10, 6 hours 44 minutes ago

Galaxy Ventures Inc. Announces Director Resignation
Published on 07/13/2026 at 21:35, 8 hours 19 minutes ago

ATHA Energy Announces Corporate Activities Update
Published on 07/13/2026 at 20:00, 9 hours 54 minutes ago

IBC Announces Share-Based Compensation to Directors

View all ACCESSWIRE

Published on 07/14/2026 at 04:45, 1 hour 9 minutes ago

Asia’s Debut of LEAP East in HKCEC Marks Hong Kong’s Largest Inaugural Tech Summit
Published on 07/13/2026 at 22:30, 7 hours 24 minutes ago

Half-year 2026 Results Media and Investor Conference Call and Webcast
Published on 07/13/2026 at 21:20, 8 hours 34 minutes ago

Evotec Announces Preliminary Second Quarter and First Half 2026 Results and Updates Full-Year 2026 Outlook
Published on 07/13/2026 at 21:17, 8 hours 37 minutes ago

EQS-Adhoc: Ad hoc: Evotec Announces Preliminary Second Quarter and First Half 2026 Results and Updates Full-Year 2026 Outlook
Published on 07/13/2026 at 20:48, 9 hours 6 minutes ago

EQS-Adhoc: Gateway Real Estate AG: Forecast for the financial year 2026

View all EQS

Published on 07/13/2026 at 18:00, 11 hours 54 minutes ago

CP Icade - Icade reprend 100% de la propriété de la Tour Eqho à la Défense
Published on 07/13/2026 at 18:00, 11 hours 54 minutes ago

PR Icade - Icade regains full ownership of the Eqho Tower in La Défense
Published on 07/13/2026 at 18:00, 11 hours 54 minutes ago

THERMADOR GROUPE : 2026 half-year turnover
Published on 07/13/2026 at 18:00, 11 hours 54 minutes ago

THERMADOR GROUPE : publication du chiffre d'affaires semestriel 2026
Published on 07/13/2026 at 17:45, 12 hours 9 minutes ago

Weekly share buyback

View all LES ECHOS COMFI WIRE

News